LUMC/PJ Futurelab offers three online learning-by-doing courses in Spring 2025. The courses are for post-graduate biomedical and pharmaceutical professionals currently working in academia, industry, business developers, Knowledge Transfer Offices (KTOs), or regulatory authorities. In these courses, you will be guided by world-renowned experts, including real-time video conferences with teachers and other participants, providing a highly interactive experience.
In addition, the courses give you access to unique tools designed to help you draft a license agreement (the License Agreement Builder), develop the most efficient clinical development program (the Questions Optimizing Calculator), and find the relevant guidelines for your product (the Market Approval Navigator).
For the courses described below, there are a limited number of scholarships available for PhDs and post-docs currently working at a Dutch university, university medical center, research center, or hospital. You can read more below.
Intellectual Property course, starting date: March 3rd, 2025
Obtaining a patent is a key step in safeguarding the intellectual property of a new biomedical product and to raise funding for development. In this course you’ll learn the pros and cons of intellectual property, as well as the main do’s and don’ts to help you protect your biomedical invention in a timely manner.
You can register here.
Clinical Product Development course, starting date: March 3rd, 2025
Clinical development plays a vital role in R&D for new products. Strengthen your expertise in determining safe and effective starting doses using NOAEL and MABEL methods, and deepen your understanding of project valuation calculations through real-world case studies. Enhance your critical reading skills by analyzing an actual Investigator’s Brochure (IB) for a First-in-Human trial. Case studies cover the development of a new antibiotic and an antibody with a novel mechanism of action, as well as a medical device and a medical nutrition product designed to treat a life-threatening disease.
You can register here.
Market Approval course, starting date: March 3rd, 2025
Obtaining market approval is an important step in the development of a new biomedical product. In this course you’ll learn how to find and interpret the relevant regulatory guidelines that will steer you through the development process. Real-world case studies, including the development of a gene therapy product and a fictitious mRNA-based vaccine, are presented to familiarize you with issues that can arise during development, as well as how to assess an Investigational Medicinal Product Dossier (IMPD).
You can register here.
Scholarships available
For courses described above a limited number of scholarships are available for post-graduate biomedical and pharmaceutical professionals )PhDs and post-docs) currently working at a university, university medical center, research center, or hospital in the Netherlands. These scholarships provide a 50% discount off the course fee. For more information, and to apply for a scholarship.
Want to learn more?
For more information about these courses check the attached brochures or visit the website.
Who are we?
Paul Janssen Futurelab is a non-profit education and training initiative of the Leiden University Medical Center (LUMC) in the Netherlands. We develop online and on campus post-graduate courses for professionals working in the life sciences.